Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

A study finds direct evidence to support guideline changes that promote lower targets for low-density lipoprotein cholesterol ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

Food insecurity is a growing problem, linked with higher rates of hospitalization and chronic illness. With 1 in 7 children ...

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...

Primary endpoint didn’t reach significance, but secondary endpoints showed nausea reduction with herbal supplement from ...

SGLT2 inhibitor therapy is linked to an increased risk for diabetic ketoacidosis in adults with T2D, particularly among those ...

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients ...

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Discontinuation of antipsychotics during pregnancy is linked to a 60% increased risk for relapse in women with primary ...

Epstein-Barr virus-positive infectious mononucleosis (EBV-mono) is associated with a threefold higher multiple sclerosis risk ...

In a head-to-head comparison of telemedicine and on-site care in postacute stroke rounds, teleneurology outperforms in-person ...